Scientific research has gifted us with a range of evidence-based options to protect ourselves from getting infected with HIV.

HIV treatment stops the HIV replication that causes immune damage. But there are places in the body where the virus "hides" ...

Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?

Lenacapavir has demonstrated enormous potential as a new HIV prevention tool with a 100 per cent efficacy rate and zero ...

Jeremy Gregson was sitting in his Northwest Indiana home two years ago when he got the call that his blood work from earlier ...

HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.

Raised by his aunt after the death of his parents, Nkumbu recalls her heartbreak the day he was suspended from school for ...

Gilead's lenacapavir approval by the US Food and Drug Administration (FDA) marks a milestone in HIV prevention, but experts warn over its expense. Sophie Cousins reports.

Matthew Hartle, Aliveness Project Medical Director, joined Amy Hockert on FOX 9's All Day on Thursday to talk about a new HIV prevention drug being offered.

As Obergefell v Hodges turns 10 years, LGBTQ+ rights face renewed threats amid political shifts, impacting health care equity ...

Tens of millions of people worldwide live with HIV. Lenacapavir can prevent the virus for months with one injection — a ...

Chicagoland research labs and community clinics are navigating illegal funding stoppages, censorship, and increasing ...